PACS Group (NYSE:PACS) CEO Sells $95,295.20 in Stock

by · The Markets Daily

PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 1,904 shares of the firm’s stock in a transaction that occurred on Thursday, October 29th. The shares were sold at an average price of $50.05, for a total transaction of $95,295.20. Following the completion of the transaction, the chief executive officer owned 54,179,397 shares in the company, valued at $2,711,678,819.85. The trade was a 0.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

  • On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The shares were sold at an average price of $50.10, for a total transaction of $345,639.90.
  • On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The stock was sold at an average price of $48.60, for a total transaction of $3,349,366.20.
  • On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The stock was sold at an average price of $47.55, for a total transaction of $651,244.80.
  • On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total transaction of $314,768.20.
  • On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total transaction of $1,785,779.05.
  • On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total transaction of $77,063.40.
  • On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total transaction of $402,875.82.
  • On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The stock was sold at an average price of $47.27, for a total transaction of $5,201,354.45.
  • On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total value of $10,440.00.
  • On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total value of $30,458.16.

PACS Group Stock Down 3.9%

Shares of PACS traded down $1.92 during midday trading on Friday, reaching $47.76. 591,191 shares of the company were exchanged, compared to its average volume of 824,846. The stock has a 50-day moving average price of $44.21 and a 200-day moving average price of $39.79. The company has a market cap of $7.56 billion, a price-to-earnings ratio of 27.77, a P/E/G ratio of 1.55 and a beta of -0.08. PACS Group, Inc. has a 1-year low of $10.31 and a 1-year high of $50.38. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21.

PACS Group (NYSE:PACS – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. Research analysts expect that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have issued reports on PACS. Truist Financial set a $62.00 price objective on shares of PACS Group in a research report on Wednesday, September 2nd. Royal Bank Of Canada boosted their target price on shares of PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Wall Street Zen downgraded shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. UBS Group raised their price target on shares of PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, Oppenheimer lifted their price target on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Five analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, PACS Group presently has an average rating of “Moderate Buy” and an average target price of $58.80.

Check Out Our Latest Report on PACS

Hedge Funds Weigh In On PACS Group

Several institutional investors and hedge funds have recently made changes to their positions in PACS. Vise Technologies Inc. grew its position in shares of PACS Group by 40.6% during the third quarter. Vise Technologies Inc. now owns 7,209 shares of the company’s stock worth $300,000 after buying an additional 2,081 shares in the last quarter. State of Wyoming raised its holdings in PACS Group by 11.9% in the third quarter. State of Wyoming now owns 10,551 shares of the company’s stock valued at $438,000 after acquiring an additional 1,119 shares in the last quarter. Smith Group Asset Management LLC boosted its stake in PACS Group by 1.3% during the 3rd quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock valued at $1,025,000 after acquiring an additional 320 shares during the last quarter. Jacobsen Capital Management boosted its stake in PACS Group by 3.4% during the 3rd quarter. Jacobsen Capital Management now owns 17,837 shares of the company’s stock valued at $741,000 after acquiring an additional 579 shares during the last quarter. Finally, Oppenheimer & Co. Inc. bought a new position in PACS Group during the 3rd quarter valued at $463,000.

About PACS Group

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

Read More